Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 7/2002

01-09-2002

Traffic patterns and childhood cancer incidence rates in California, United States

Authors: Peggy Reynolds, Julie Von Behren, Robert B. Gunier, Debbie E. Goldberg, Andrew Hertz, Daniel Smith

Published in: Cancer Causes & Control | Issue 7/2002

Login to get access
Metadata
Title
Traffic patterns and childhood cancer incidence rates in California, United States
Authors
Peggy Reynolds
Julie Von Behren
Robert B. Gunier
Debbie E. Goldberg
Andrew Hertz
Daniel Smith
Publication date
01-09-2002
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 7/2002
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1019579430978

Other articles of this Issue 7/2002

Cancer Causes & Control 7/2002 Go to the issue

OriginalPaper

Risk factors for myelodysplastic syndromes: a case–control study in Greece

OriginalPaper

Risk factors for progression of squamous cell cervical carcinoma in-situ to invasive cervical cancer: results of a multinational study

OriginalPaper

A case–control study of lung cancer in Casablanca, Morocco

OriginalPaper

Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States)

OriginalPaper

Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland)

OriginalPaper

A nested case–control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits